Wealth Shield Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wealth Shield Partners, LLC

  • $721 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$548.35 - $738.84 $1.07 Million - $1.44 Million
-1,955 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$595.12 - $698.43 $1.16 Million - $1.37 Million
1,955 New
1,955 $1.37 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $28,701 - $34,048
-50 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $22,336 - $27,410
50 New
50 $24,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wealth Shield Partners, LLC Portfolio

Follow Wealth Shield Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email